[HTML][HTML] Role of the IL-23/IL-17 pathway in chronic immune-mediated inflammatory diseases: mechanisms and targeted therapies
E Bianchi, M Vecellio, L Rogge - Frontiers in Immunology, 2021 - frontiersin.org
… ) cells, which secrete the pro-inflammatory cytokine IL-17 (14), but it may … IL-23/IL-17 biology,
and of the many cell types involved, may lead to the identification of new therapeutic targets…
and of the many cell types involved, may lead to the identification of new therapeutic targets…
The treatment with interleukin 17 inhibitors and immune-mediated inflammatory diseases
L Țiburcă, M Bembea, DC Zaha, AD Jurca… - Current Issues in …, 2022 - mdpi.com
… Interleukin-17 (IL-17) is one of the well-studied cytokines as an important player in the … of
the mechanism of IL-23-Th17 cell, IL-17, which has allowed for more targeted treatments and …
the mechanism of IL-23-Th17 cell, IL-17, which has allowed for more targeted treatments and …
Role of the IL-23/IL-17 pathway in rheumatic diseases: an overview
C Schinocca, C Rizzo, S Fasano, G Grasso… - Frontiers in …, 2021 - frontiersin.org
… shown to exacerbate chronic immune-mediated inflammation. Well-… production of the cytokines
(TNF-α, IL-17, IL-6, IL-23) involved in … of new potential therapeutic targets of inflammatory …
(TNF-α, IL-17, IL-6, IL-23) involved in … of new potential therapeutic targets of inflammatory …
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
K Ghoreschi, A Balato, C Enerbäck, R Sabat - The Lancet, 2021 - thelancet.com
… of the cytokines of this pathway; in fact, therapeutics that specifically target IL-23, IL-17, and
IL-… in other immune-mediated diseases such as Crohn's disease, spondylarthritis, and coeliac …
IL-… in other immune-mediated diseases such as Crohn's disease, spondylarthritis, and coeliac …
IL-23/IL-17 axis in inflammatory rheumatic diseases
… IL-17, the signature cytokine, have led to important insights into chronic inflammation.
Interleukin-23 (IL-23), a heterodimeric cytokine … of pro-inflammatory cytokines including IL-17, IL-22…
Interleukin-23 (IL-23), a heterodimeric cytokine … of pro-inflammatory cytokines including IL-17, IL-22…
Biologic therapies targeting the interleukin (IL)‐23/IL‐17 immune axis for the treatment of moderate‐to‐severe plaque psoriasis: a systematic review and meta …
CY Erichsen, P Jensen, K Kofoed - Journal of the European …, 2020 - Wiley Online Library
… inflammatory immune-mediated skin disease that … of IL-23 and IL-17 in the pathogenesis of
psoriasis has led to the development of many new biologic therapies targeting these cytokines…
psoriasis has led to the development of many new biologic therapies targeting these cytokines…
IL-23/Th17 axis: a potential therapeutic target of psoriasis
… Abstract: Psoriasis is an immune-mediated skin disease that … , we review the IL-23/Th-17
axis based therapeutic targets, … and IL-23, the different isoforms of IL-17, the IL-17 receptor …
axis based therapeutic targets, … and IL-23, the different isoforms of IL-17, the IL-17 receptor …
Tissue-specific therapy in immune-mediated kidney diseases: new ARGuments for targeting the IL-23/IL-17 axis
CF Krebs, JE Turner, JH Riedel… - The Journal of Clinical …, 2021 - Am Soc Clin Investig
… Most cytokines of the IL-23/IL-17 family act locally rather than systemically. Therefore, it can
be … the IL-23/IL-17 pathway as a key driver of immune-mediated kidney diseases. A direct …
be … the IL-23/IL-17 pathway as a key driver of immune-mediated kidney diseases. A direct …
Interleukin 23 and autoimmune diseases: current and possible future therapies
… of both IL-17 and IL-22 arms. This made IL-23 a key target of autoimmune disorders therapy,
which … Immune-mediated disorders are conditions characterized by an uncontrolled immune …
which … Immune-mediated disorders are conditions characterized by an uncontrolled immune …
New insights into the IL-12 and IL-23: From a molecular basis to clinical application in immune-mediated inflammation and cancers
IT Chyuan, JH Lai - Biochemical pharmacology, 2020 - Elsevier
… We discuss the therapeutic rationale for targeting these cytokines to treat … of therapies
targeting IL-23 in AS and axSpA suggests the possibility of a partial uncoupling of IL-23 and IL-17 …
targeting IL-23 in AS and axSpA suggests the possibility of a partial uncoupling of IL-23 and IL-17 …